NCI-N87-hCLDN18.2-Tg
品系基本信息
驗(yàn)證數(shù)據(jù)
Ⅰ.In vitro?Expression of NCI-N87-hCLDN18.2 cell line
The hCLDN18.2?protein expression in the wild-type NCI-N87 and NCI-N87- hCLDN18.2 cells were measured by Flow Cytometry.
Figure?1. hCLDN18.2 expression in NCI-N87 and NCI-N87-hCLDN18.2 cell lines
Ⅱ.Characterization of in vivo?growth kinetics
To test the take rates, and?the tumor growth characteristics of NCI-N87-hCLDN18.2 cell line, cells?were subcutaneously inoculated into the M-NSG mice.
Figure?2. Tumor growth curve of NCI-N87-hCLDN18.2 xenograft model (n=5)
Figure?3. Body weight change of NCI-N87-hCLDN18.2 xenograft model?model (n=5)
Ⅲ.Expression of hCLDN18.2 protein in tumors
To verify the hCLDN18.2 protein expression, the tumors were dissected and separated for single cell suspension.
Figure?4. The expression of hCLDN18.2 in humanized modified tumors by FACS
你也可能感興趣
Cre-ERT2在無Tamoxifen誘導(dǎo)的情況下，在細(xì)胞質(zhì)內(nèi)處于無活性狀態(tài)；當(dāng)Tamoxifen誘導(dǎo)后，Tamoxifen的代謝產(chǎn)物4-OHT（雌激素類似物）與ERT結(jié)合，可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見的基因工程小鼠可以分為兩種命名方式，包括基因定點(diǎn)修飾的小鼠命名，比如：敲除、敲入、點(diǎn)突變等等，和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看
